| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/11/2003 | WO2003101476A1 Active agent delivery systems and methods for protecting and administering active agents |
| 12/11/2003 | WO2003101467A1 Pharmaceutical compositions comprising abacavir and lamivudine |
| 12/11/2003 | WO2003101465A1 Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 12/11/2003 | WO2003101461A1 Norethindrone sustained release formulations and methods associated therewith |
| 12/11/2003 | WO2003101454A1 A buffered, liquid nicotine composition for pulmonary administration |
| 12/11/2003 | WO2003101451A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 12/11/2003 | WO2003101445A1 Intravenous rifalazil formulation and methods of use thereof |
| 12/11/2003 | WO2003101439A1 Medicament containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol in different formulations for treating urinary incontinence |
| 12/11/2003 | WO2003101438A1 Treatment for human papillomavirus |
| 12/11/2003 | WO2003101435A2 Compound medicine |
| 12/11/2003 | WO2003101434A2 Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
| 12/11/2003 | WO2003101433A1 Plaster containing fentanyl |
| 12/11/2003 | WO2003101432A1 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 12/11/2003 | WO2003101431A1 Pharmaceutical composition for controlled drug delivery system |
| 12/11/2003 | WO2003101430A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 12/11/2003 | WO2003101429A1 A hemostatic composition |
| 12/11/2003 | WO2003101428A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
| 12/11/2003 | WO2003101427A1 Immunoliposomes formed with aggregated antibody |
| 12/11/2003 | WO2003101426A2 Simple and multiple emulsions for decontamination of an organism or surfaces |
| 12/11/2003 | WO2003101425A2 Therapeutic agent-containing polymeric nanoarticles |
| 12/11/2003 | WO2003101424A1 Modified release pharmaceutical formulation |
| 12/11/2003 | WO2003101423A1 Immediate release pharmaceutical formulation |
| 12/11/2003 | WO2003101422A2 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 12/11/2003 | WO2003101421A1 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 12/11/2003 | WO2003101420A1 Film-shaped, dissolvable preparations for active substance release and method for the production thereof |
| 12/11/2003 | WO2003101404A2 Preparations for topical skin use and treatment |
| 12/11/2003 | WO2003101395A2 Formulations for amylin agonist peptides |
| 12/11/2003 | WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 12/11/2003 | WO2003101384A2 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| 12/11/2003 | WO2003101383A2 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 12/11/2003 | WO2003101378A2 Pharmaceutical formulation in a drug delivery system and process for preparing the same |
| 12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
| 12/11/2003 | WO2003101361A1 Delivery system for flowable medicinal or therapeutic substances |
| 12/11/2003 | WO2003101358A1 Implantable polymeric device for sustained release of buprenorphine |
| 12/11/2003 | WO2003101357A1 Transmucosal delivery of cannabinoids |
| 12/11/2003 | WO2003101217A1 Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 12/11/2003 | WO2003101196A1 Antimicrobial envelopes |
| 12/11/2003 | WO2003075894A8 A system for the controlled release of active ingredients |
| 12/11/2003 | WO2003066123A3 Microinfusion device |
| 12/11/2003 | WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 12/11/2003 | WO2003059333A3 Stimulation of the immune system with polydextrose |
| 12/11/2003 | WO2003051300A3 Metal complexes and formulations of rifamycin analogues and uses therof |
| 12/11/2003 | WO2003050190A3 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 12/11/2003 | WO2003045610A3 Nano-dispersed powders and methods for their manufacture |
| 12/11/2003 | WO2003043601A3 Modular systems for the controlled release of a substance with space and time control |
| 12/11/2003 | WO2003043584A3 Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins |
| 12/11/2003 | WO2003035827A3 Plasticized hydrophilic glasses for improved stabilization of biological agents |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 12/11/2003 | WO2003002142A8 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 12/11/2003 | WO2003000241A3 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 12/11/2003 | WO2002094273A3 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| 12/11/2003 | WO2002094228A9 Prevention and treatment of allergies by helminthic regulation of ige |
| 12/11/2003 | WO2002094222A3 Method for the production of nanodispersions |
| 12/11/2003 | WO2002080883A3 Method and composition for solubilising a biologically active compound with low water solubility |
| 12/11/2003 | WO2002078648A3 Topical composition comprising an antifungal |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002041884A8 Inhibitors of abc drug transporters at the blood-brain barrier |
| 12/11/2003 | US20030229390 On-stent delivery of pyrimidines and purine analogs |
| 12/11/2003 | US20030229337 Implantable pressure-activated micro-valve |
| 12/11/2003 | US20030229336 Cochlear drug delivery system and method |
| 12/11/2003 | US20030229335 Infection therapy; sustained release |
| 12/11/2003 | US20030229333 Sustained release of drug into ear tissue; side effect reduction |
| 12/11/2003 | US20030229185 Crosslinking, nanoparticle sizes |
| 12/11/2003 | US20030229158 High molecular weight, water soluble polymer; shell containing drug |
| 12/11/2003 | US20030229141 N-acetyl cysteine and its topical use |
| 12/11/2003 | US20030229136 Anticancer agents; antiproliferative agents |
| 12/11/2003 | US20030229122 Use of methylphenidate compounds to enhance memory |
| 12/11/2003 | US20030229111 Naltrexone hydrochloride compositions |
| 12/11/2003 | US20030229101 Tablets comprising ciprofloxacin hydrochloride |
| 12/11/2003 | US20030229061 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 12/11/2003 | US20030229057 Continuous sulfatase inhibiting progestogen hormone replacement therapy |
| 12/11/2003 | US20030229056 Composition for aqueous stabilization of fat-soluble vitamins |
| 12/11/2003 | US20030229049 Injectable mixture of chondrosamine sulfate, glucosamine hydrochloride, dimethyl sulfoxide and dextrose with anesthetic |
| 12/11/2003 | US20030229048 Skin disorders; antiinflammatory agents |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |
| 12/11/2003 | US20030229040 Anticancer agents; complexing with lipids |
| 12/11/2003 | US20030229037 Novel cationic amphiphiles |
| 12/11/2003 | US20030229028 Complexing drug with spacer and galactose |
| 12/11/2003 | US20030229027 In mixture of sugar and,or sugar alcohol |
| 12/11/2003 | US20030229025 Antidiabetic agents, eating disorders, dietetics |
| 12/11/2003 | US20030229022 Sustained release; angigenesis inhibitors |
| 12/11/2003 | US20030229017 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 12/11/2003 | US20030229013 Drug delivery |
| 12/11/2003 | US20030229010 Antidiabetic agents; water in oil microemulsion; immobilization |
| 12/11/2003 | US20030229006 Amphiphilic oligomers |
| 12/11/2003 | US20030228395 Isotropic transparent structured fluids |
| 12/11/2003 | US20030228382 Foot Fixer Kit |
| 12/11/2003 | US20030228378 Water-soluble stable salts of petroselinic acid |
| 12/11/2003 | US20030228372 Animal extract in cyclodextrin matrix; antiaging agents, immunology response |
| 12/11/2003 | US20030228370 Orodispersible solid pharmaceutical form |
| 12/11/2003 | US20030228369 Process for conversion of high viscosity fluids and compositions thereof |
| 12/11/2003 | US20030228368 Edible solid composition and dosage form |
| 12/11/2003 | US20030228367 Liquid crystalline polymers |
| 12/11/2003 | US20030228366 Uniformity stable colloid solution |
| 12/11/2003 | US20030228365 Pharmaceutical formulation |
| 12/11/2003 | US20030228363 Stabilized pharmaceutical compositons containing benzimidazole compounds |
| 12/11/2003 | US20030228362 Controlled release lipoic acid |
| 12/11/2003 | US20030228361 Hypotensive agents; cardiovascular disorders |